ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
May 10, 2004
Elite Grants Purdue Exclusive Right to Evaluate Its Abuse Resistance Drug Formulation Technology
May 03, 2004
Elite Pharmaceuticals Announces Closing of Settlement of Litigation with Former CEO
Apr 01, 2004
Elite Pharmaceuticals Announces Settlement of Litigation with Former CEO
Mar 09, 2004
Elite Pharmaceuticals Announces Extension of B Warrants
Mar 05, 2004
Elite Completes Registration Batches for Allergy Product
Dec 23, 2003
ELITE LABORATORIES AND PIVOTAL DEVELOPMENT ANNOUNCE COLLABORATION ON SUSTAINED RELEASE GENERIC PRODUCT
Dec 04, 2003
Elite Pharmaceuticals Completes $3,290,000 Private Placement
Sep 23, 2003
Elite Pharmaceuticals Announces Revised Exchange Offer
Aug 08, 2003
Elite Pharmaceuticals Authorizes Negotiation of Merger with Nostrum Pharmaceuticals
Jun 04, 2003
Elite Pharmaceuticals Comments on Resignation of Former CEO, Announces New Management Team
25
26
27
28
29
30
<<
<
>
>>
Back to top
Privacy
